On January 22, 2024, Bridge Biotherapeutics, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,090 KRW | -2.34% | -9.91% | -36.38% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.38% | 37.39M | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-4.25% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- A288330 Stock
- News Bridge Biotherapeutics, Inc.
- Bridge Biotherapeutics, Inc. announced that it has received KRW 1.99999872 billion in funding